Free tool
Stocks listed on Nasdaq GM
We cover 158 companies listed on Nasdaq GM. The median market value in the group is $863.54M. Across the group, the median move over the past trading day is −0.55%. 61% of the 158 with a 200-day average trade above it. Price change over the past year runs from −43.1% to +228.0% across the middle 80 percent of the group, with a median of +29.8%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
158 of 701 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| AXSM | Axsome Therapeutics, Inc. | $207.15 | −11.55% | +15.93% | +69.99% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% |
| PTGX | Protagonist Therapeutics, Inc. | $151.50 | +10.71% | +73.78% | +146.62% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $111.87 | +3.54% | +6.53% | +9.35% |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $99.44 | +9.94% | +251.75% | +555.07% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $63.79 | −1.77% | +43.38% | +64.11% |
| RDNT | RadNet, Inc. | $76.47 | +20.96% | +7.78% | +7.27% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.51 | −12.22% | +26.18% | +31.96% |
| LGND | Ligand Pharmaceuticals Incorporated | $287.85 | −2.85% | +51.41% | +80.92% |
| CRSP | CRISPR Therapeutics AG | $59.23 | +24.56% | +10.15% | +10.65% |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GPCR | Structure Therapeutics Inc. | $49.35 | +3.05% | −27.55% | +159.74% |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.40 | −2.07% | −22.16% | +11.97% |
| TMDX | TransMedics Group, Inc. | $92.22 | +20.88% | −24.83% | −21.43% |
| IRON | Disc Medicine, Inc. | $82.67 | +10.74% | +4.53% | +37.90% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| VERA | Vera Therapeutics, Inc. | $36.82 | +10.50% | −24.27% | +67.21% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $44.88 | −5.97% | −9.28% | −0.42% |
| TRVI | Trevi Therapeutics, Inc. | $17.92 | −2.77% | +50.71% | +124.00% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| KOD | Kodiak Sciences Inc. | $39.33 | −2.38% | +51.15% | +321.09% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| OCUL | Ocular Therapeutix, Inc. | $10.77 | +27.46% | −8.88% | −12.58% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.54 | +10.56% | +7.75% | +36.58% |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| GHRS | GH Research PLC | $29.01 | +3.76% | +119.11% | +112.84% |
| NTLA | Intellia Therapeutics, Inc. | $13.19 | +21.12% | +43.21% | +15.50% |
| SEPN | Septerna, Inc. | $40.25 | +18.49% | +43.85% | +218.81% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| LMAT | LeMaitre Vascular, Inc. | $79.61 | −22.18% | −0.22% | −16.20% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| ALVO | Alvotech | $4.91 | +58.39% | −1.80% | −38.85% |
| ANIP | ANI Pharmaceuticals, Inc. | $74.56 | −8.00% | −4.93% | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $29.58 | +6.10% | −25.62% | +113.27% |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% |
| AAPG | Ascentage Pharma Group Internat | $16.90 | −7.57% | −35.91% | −59.18% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $21.37 | +20.33% | −0.84% | +74.45% |
| PAHC | Phibro Animal Health Corporation | $36.09 | −0.77% | −3.02% | +13.01% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| MNKD | MannKind Corporation | $4.09 | +4.60% | −26.96% | −9.51% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% |
| PRCT | PROCEPT BioRobotics Corporation | $21.07 | +16.54% | −31.50% | −48.36% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| STAA | STAAR Surgical Company | $22.86 | +0.88% | −3.14% | −16.90% |
| IVA | Inventiva S.A. | $4.82 | +3.88% | +1.26% | −7.84% |
| IRMD | IRADIMED CORPORATION | $87.47 | −7.76% | −8.02% | +19.80% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| WVE | Wave Life Sciences, Inc. | $5.23 | −11.21% | −67.21% | −48.12% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| ARDX | Ardelyx, Inc. | $3.83 | −24.68% | −37.72% | −38.13% |
| CLYM | Climb Bio Inc | $16.08 | +30.84% | +328.80% | +603.72% |
| ANL | Adlai Nortye Ltd. | $15.06 | +18.68% | +991.30% | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $17.03 | +0.83% | −6.17% | +23.41% |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% |
| AVR | Anteris Technologies Global Corp. | $8.95 | +9.55% | +81.91% | +144.54% |
| SIBN | SI-BONE, Inc. | $19.43 | +8.37% | −1.82% | +17.12% |
| PHAR | Pharming Group N.V. | $11.95 | −7.08% | −30.28% | −14.47% |
| SLN | Silence Therapeutics plc | $13.53 | +17.14% | +120.00% | +160.19% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +45.87% |
| AURA | Aura Biosciences, Inc. | $7.73 | +9.65% | +45.85% | +20.03% |
| NGNE | Neurogene Inc. | $38.41 | +15.62% | +90.53% | +95.02% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.26 | +7.80% | −24.65% | −0.43% |
| OCS | Oculis Holding AG | $12.97 | +17.32% | −35.15% | −25.14% |
| XOMA | XOMA Royalty Corp | $40.17 | 0.00% | +43.52% | +19.27% |
| TECX | Tectonic Therapeutic, Inc. | $35.97 | +20.70% | +72.02% | +35.43% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| CRMD | CorMedix Inc. | $8.39 | +14.15% | −31.00% | −40.66% |
| PRME | Prime Medicine, Inc. | $3.58 | +15.86% | +1.42% | +4.37% |
| KIDS | OrthoPediatrics Corp. | $24.03 | +21.12% | +36.85% | +11.10% |
| ALT | Altimmune, Inc. | $3.15 | +5.35% | −10.26% | −14.17% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +11.78% | +178.25% | +259.94% |
| BWAY | BrainsWay Ltd. | $14.30 | −7.68% | +48.26% | +87.42% |
| SPRY | ARS Pharmaceuticals, Inc. | $6.03 | +6.35% | −47.52% | −55.13% |
| CERS | Cerus Corporation | $2.74 | −6.16% | +39.09% | +109.16% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | +0.92% | −22.59% | −8.46% |
| TCMD | Tactile Systems Technology, Inc. | $23.51 | −15.25% | −14.20% | +78.78% |
| NPCE | NeuroPace, Inc. | $14.68 | −4.11% | −3.23% | +65.32% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% |
| LRMR | Larimar Therapeutics, Inc. | $4.17 | +8.88% | +20.17% | +6.92% |
| EYPT | EyePoint, Inc. | $4.99 | −58.28% | −71.45% | −57.85% |
| MASS | 908 Devices Inc. | $10.37 | +47.51% | +103.73% | +64.60% |
| LXEO | Lexeo Therapeutics, Inc. | $5.01 | +14.12% | −47.87% | +3.30% |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.66 | +16.56% | +5.78% | +10.24% |
| FHTX | Foghorn Therapeutics Inc. | $6.69 | +30.41% | +28.90% | +23.66% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| TKNO | Alpha Teknova, Inc. | $7.22 | +41.85% | +85.13% | +62.25% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.89 | −15.80% | +183.94% | +113.74% |
| STRO | Sutro Biopharma, Inc. | $21.43 | −9.69% | +95.53% | +138.11% |
| CLLS | Cellectis S.A. | $3.42 | +20.42% | −28.75% | +28.09% |
| NNNN | Anbio Biotechnology | $7.72 | −23.94% | −73.81% | −83.55% |
| IMRX | Immuneering Corporation | $5.15 | +21.46% | −22.21% | −0.77% |
| VNDA | Vanda Pharmaceuticals Inc. | $5.35 | +3.68% | −35.15% | +15.80% |
| OBIO | Orchestra BioMed Holdings, Inc. | $5.26 | +36.27% | +22.04% | +85.21% |
| RNAC | Cartesian Therapeutics, Inc. | $10.19 | +33.20% | +50.74% | −4.09% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.57 | +10.78% | +159.60% | +129.46% |
| TLSI | TriSalus Life Sciences, Inc. | $4.93 | +13.86% | −19.18% | −3.33% |
| TRDA | Entrada Therapeutics, Inc. | $7.00 | +20.07% | −30.35% | +23.24% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| FULC | Fulcrum Therapeutics, Inc. | $3.86 | +3.76% | −64.65% | −41.78% |
| TTRX | Turn Therapeutics Inc. | $9.63 | +25.06% | +105.33% | +37.57% |
| SION | Sionna Therapeutics, Inc. | $6.17 | −86.75% | −84.26% | −75.45% |
| IVVD | Invivyd, Inc. | $0.90 | +52.06% | −63.93% | +3.52% |
| RXST | RxSight, Inc. | $6.38 | +5.45% | −38.54% | −25.38% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $4.20 | +22.81% | −30.00% | +178.15% |
| ADAG | Adagene Inc. | $3.85 | +3.22% | +109.24% | +75.80% |
| TARA | Protara Therapeutics, Inc. | $3.91 | −0.76% | −27.32% | +21.05% |
| STIM | Neuronetics, Inc. | $3.00 | +60.43% | +108.33% | −10.71% |
| CHRS | Coherus Oncology, Inc. | $1.45 | +0.69% | +5.84% | +27.19% |
| SIGA | SIGA Technologies, Inc. | $3.07 | −8.08% | −44.65% | −57.93% |
| KROS | Keros Therapeutics, Inc. | $11.12 | +10.43% | −40.02% | −28.35% |
| NBP | NovaBridge Biosciences | $1.87 | +6.86% | −56.21% | −58.44% |
| MSLE | Satellos Bioscience Inc. | $9.36 | −1.06% | +50.87% | +77.27% |
| AIRS | AirSculpt Technologies, Inc. | $2.72 | −41.63% | +47.03% | −57.30% |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% |
| WW | WW International, Inc. | $17.60 | +27.91% | −44.02% | −45.96% |
| QSI | Quantum-Si incorporated | $0.79 | +3.89% | −31.84% | −31.84% |
| MENS | Jyong Biotech Ltd. | $2.24 | −6.28% | −34.31% | −95.62% |
| FOCL | EDAP TMS S.A. | $4.41 | −27.23% | +29.71% | +179.11% |
| NYXH | Nyxoah SA | $1.62 | +13.29% | −64.00% | −73.74% |
| MDWD | MediWound Ltd. | $12.70 | −13.13% | −31.05% | −25.29% |
| LFMD | LifeMD, Inc. | $3.24 | −15.62% | −7.16% | −49.45% |
| OKUR | OnKure Therapeutics, Inc. | $3.80 | −3.80% | +28.38% | +35.71% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| CNTB | Connect Biopharma Holdings Limited | $2.33 | +12.02% | −7.54% | +30.90% |
| QTRX | Quanterix Corporation | $2.68 | −23.21% | −58.32% | −41.87% |
| GUTS | Fractyl Health, Inc. | $0.74 | +1.95% | −67.24% | −25.55% |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.56 | +30.66% | −48.65% | −29.30% |
| RANI | Rani Therapeutics Holdings, Inc. | $0.84 | +2.74% | −38.13% | +49.45% |
| CCLD | CareCloud, Inc. | $2.64 | +11.86% | −9.28% | −28.84% |
| BNR | Burning Rock Biotech Limited | $10.44 | +13.60% | −46.95% | +22.54% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.